Request a Report Request a Demo
Oct 7, 2022

Milliman IntelliScript® Acquires OneRecord

Contact: Jeremy Engdahl-Johnson
Milliman, Inc.
Tel: 646 473 3021

October 7, 2022 (Milwaukee)—Milliman IntelliScript®, an insurtech company with risk assessment solutions for life and health insurers, has acquired OneRecord, a digital healthcare company that empowers consumers to access, aggregate, and share their healthcare data with the people and organizations they trust using standards-based APIs.

OneRecord has two products: a consumer application, called OneRecord, that enables consumers to retrieve their own clinical and financial healthcare information for free, and a business-facing application programming interface, called OneRecord API, that can deliver electronic health records (EHR) and claims data with consent for insurance underwriting and clinical trials.

The purchase of OneRecord positions Milliman IntelliScript to better serve clients who depend on the company’s delivery of digital health and consumer data to mitigate applicant risks, meet customer demand for a faster application process, and extend coverage to more people. It also places Milliman IntelliScript at the forefront of technologies that give consumers input into how, when, and with whom their health data is shared. “We’ve always taken a very collaborative approach to working with our clients, and they’ve told us they want more tools for assessing risk with consumer consent through every stage of their evaluation processes,” says Chris Martin, Principal and Managing Director at Milliman IntelliScript. “Now that we’ve brought in this bundle of talent and assets, we can more quickly develop the additional data-driven products they’ve asked us for while continuing to grow and improve those they rely on now.”

The OneRecord consumer application will remain in operation with its free EHR consolidation service. OneRecord CEO and co-founder Jennifer Blumenthal will join Milliman IntelliScript, where she will further the effort to help patients exercise their right under the 21st Century Cures Act to access and control their health information via consumer-directed exchange. “OneRecord has led the way for consumers to access, manage, and share their health data through an app of their choice,” says Blumenthal. “Our success has brought us to the point where we have to expand to keep serving our users. Milliman IntelliScript’s resources and extensive clinical data expertise couldn’t have come at a better time for OneRecord, and we’re excited that this deal carries our founding mission forward.”

About Milliman IntelliScript
Milliman IntelliScript is the leading creator of risk-assessment insurtech for the U.S. life and health insurance sectors. Our actuaries, clinicians, developers, and data scientists combine deep technical expertise and a pragmatic focus on demonstrable ROI to invent and relentlessly improve data-driven SaaS solutions that help carriers make better decisions faster and more confidently. For over 20 years, our customers have known us as category-defining innovators and reliable strategic partners. They count on us to clarify both risks and opportunities—so they can see more and fear less. See more at

Milliman IntelliScript is part of Milliman, Inc., an independent risk management, benefits, and technology firm. Milliman helps clients around the world as they take on some of the world’s most critical and complex issues, including retirement funding and healthcare financing, risk management and regulatory compliance, data analytics and business transformation. More information is at

About OneRecord, LLC
OneRecord is the leader in FHIR interoperability with integrations to provider and payer organizations across the United States and Europe. Its data network powers healthcare tools that people and developers rely on. OneRecord makes it easy for people to connect their healthcare data to apps and services they want to use. OneRecord’s network covers healthcare institutions and health insurance plans. The company was founded in 2016 and headquartered in New York City. Learn more at